Vaxrevia Data Release

Hold onto your shirt. MHRA have answered the VaxRevia questions:

The Oxford/AstraZeneca (Vaxrevia) vaccine, indicated in adults, was linked to a rare but serious side effect called thrombosis with thrombocytopenia syndrome (TTS). On 27 March 2024, the European Com…